MediXall Group, Inc. Has Hit Significant Milestones and Now is Ready to Expand


MediXall Group, Inc. Names Michael Swartz President and Guy Conner Executive Vice President

FORT LAUDERDALE, FL., April 11, 2018 (GLOBE NEWSWIRE) -- -- MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, announced today that several significant milestones have been completed. Over the past year, MediXall has made significant progress on the Company’s strategic initiatives by achieving the following:

Launched MediXall Platform
In March 2018, we completed development of the MediXall Healthcare Marketplace and initiated a controlled launch in South Florida, specifically in the counties of Palm Beach, Broward, and Miami Dade. The South Florida launch consists of a select group of MediXall early adopters who completed the onboarding process and were approved by the credentialing committee. With MediXall’s 5,500+ registered healthcare providers continuing to complete their legal agreements and the subsequent process of credentialing, the full launch with all medical services available is on track for the second quarter of 2018.

Established MediXall Finance Group
In May 2017, MediXall partnered with Crossroads Capital Finance Group to offer financial products to our MediXaid Provider Network members, to assist them in developing their businesses and client/patient relationships. Based on the success of the joint venture, MediXall Group purchased the Health Care division of Crossroads Capital Finance and has set up a MediXall Group division called MediXall Finance Group.

Due to these significant achievements, MediXall has named Michael Swartz to President and Guy Connor to Executive Vice President of the company.  Swartz previously served as MediXall’s Vice President of Operations, and Connor was the company’s Director of Business Development.

“When TBG Venture Capital made its investment in MediXall we set up the strategic and operational goals” said Neil Swartz, CEO of MediXall.  Swartz continued “Looking back on the past year, I am proud to say we have achieved these milestones. It was an extraordinary year of growth for our company.  We also acted to create a more focused and efficient company and enhance the depth of talent on our Board and management team. As a result, MediXall is better positioned to drive increased levels of profitable growth and enhance shareholder value.  With this we are promoting Michael Swartz and Guy Connor because of the value they have brought to the Company to date. We are so pleased to announce the promotions of Michael and Guy, both seasoned professionals who will oversee all MediXall’s operations. In the coming year, I look forward to continued progress on our journey to transform the healthcare industry.”

Since joining the MediXall Management team in late 2015, Michael Swartz has led product development projects and has been directly responsible for bringing the MediXall Healthcare Marketplace to launch.  Prior to joining MediXall, he was a Co-founder of Viridian Capital Advisors and served as a Senior Analyst from 2013 - 2015, where he led all modeling and valuation work for the firm’s M&A and fundraising assignments.

Before that, he was a co-portfolio manager for the Osprey Financial Group, where he analyzed publicly traded companies with market capitalizations from $50 million to $1 billion and prepared buy-side equity reports containing buy-recommendations and original valuations derived from fundamental & technical analysis. In addition, Mr. Swartz served as the fund’s Asian Economist, analyzing economic and geopolitical factors and assessing the Asia-Pacific region for attractive investment opportunities.

In his previous role as Director of Business Development for MediXall Group, Guy Connor provided solid guidance on the current state of the technology sector and the strongest courses of action for the MediXall Healthcare Platform, as well as advising on cyber security and data management for all of the company programs. Mr. Connor has over 25 years of experience as an internationally recognized industry leader in the technology sector, with notable successes in building and growing companies that produce ecommerce software, mobile entertainment portals, and banking middleware platforms. In 1991, he co-founded CDM, a data brokerage and Management Company and pioneered client acquisition strategies for financial services firms within North America and Europe. Mr. Connors acquisition models became the bench-mark for the emerging subprime mortgage industry; subsequently he was appointed by Equifax to establish early compliance protocols of the FCRA credit amendment act of 1994/1995 as well as working with Companies to expand their reach into the UK through Equifax Europe and the British government.

Under the leadership of Michael Swartz and Guy Connor, MediXall has established three divisions: 1) MediXall Healthcare Marketplace (formerly MediXaid), a new generation healthcare marketplace platform that promises to revolutionize the way people purchase healthcare goods and services; 2) MediXall Finance Group, and 3) MediXall Investment Group.

For more information, please visit www.medixall.com or call (954) 440-4678.

About MediXall Healthcare Platform
The first product MediXall is developing is the MediXall Healthcare Marketplace, a new generation healthcare platform, which addresses the immediate need of self-pay and high deductible consumers, price competition and healthcare costs transparency.  The platform allows consumers to find self-pay medical treatments at more affordable costs. With MediXall.com, patient/clients find price transparency and the ability to make informed choices based on price, location and schedule for requested medical products and services. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based MediXall platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer.

About MediXall Group, Inc.
MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol “MDXL.” The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. MediXall’s first acquisition was MediXaid®, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


        

Contact Data